feed,title,long_url,short_url
Benzinga,"Premature Rate Cuts Could Please Markets But Spell Trouble For Fed, Warns El-Erian: 'That Would Not Be New'",https://benzinga.com/analyst-ratings/analyst-color/23/12/36279142/premature-rate-cuts-could-please-markets-but-spell-trouble-for-fed-warns-el-erian-t,https://da.gd/qF6f
Benzinga,FDA Approves Arcutis Biotherapeutics' Lead Drug For Scaly Skin Disorder,https://benzinga.com/general/biotech/23/12/36278433/fda-approves-arcutis-biotherapeutics-lead-drug-for-scaly-skin-disorder,https://da.gd/eVZc6y
